Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

Back to signals Ask the Agent

SUZBullishEarningsShort Term

High materiality8/10

Suzano Reports Adjusted EBITDA of R$4.7 Billion in the Second Quarter of 2026

StockNews.AIAug 12, 7:27 PM EDT1 source

Trading thesisImportance 8/10

Bullish over the next 3-6 months as Arbex integration and deleveraging support margins.

AI summary

What happened and why it matters

Suzano posted stronger Q2 2026 results with higher pulp and paper volumes, supported by rising prices. Adjusted EBITDA and operating cash flow improved despite FX headwinds and input-cost pressure. The completion of Arbex (51% stake) for USD 1.3 billion adds a global tissue platform, with consolidation from Q3 2026 and potential earnings uplift.

Arbex deal closes; consolidation starts in Q3 2026.
2Q26 revenue and EBITDA beat versus prior quarter.
Deleveraging path could improve credit metrics.
Hedging reduces Brent price volatility; oil-price sensitivity remains.

Sentiment rationale

Solid Q2 beat on revenue/EBITDA, strong cash flow, and a transformative Arbex acquisition raise earnings power; deleveraging path supports multiple expansion potential; near-term catalysts include Q3 consolidation benefits.

Key facts

01
Suzano 2Q26: higher prices and stronger volumes; Adj EBITDA up.
02
Net revenue BRL 11.6B; Adj EBITDA BRL 4.7B; operating cash BRL 2.9B.
03
Leverage at 3.4x; deleveraging focus.
04
Acquired Arbex 51% stake for USD 1.3B; consolidation from Q3 2026.
05
FX headwinds and higher input costs persist; hedges mitigate Brent risk.

Earnings

Earnings and corporate developments in the packaging/tissue sector, combining a quarterly beat with strategic M&A.